Pfizer Inc (PFE) 35.71 $PFE
Bull Chart of the Day: Pfizer
at The Street - 2 hrs 48 mins ago
PFE now has a very large bull flag with the potential to push the shares higher.
PFE: 35.71 (+0.36)
Stock Market News for July 29, 2015 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Jul 29, 9:10AM CDT
Benchmarks gained over 1% on Tuesday as investors focused on upbeat earnings results, ignoring the selloff in China’s stock market
BIIB: 311.50 (-8.43), F: 15.12 (+0.29), RIG: 14.33 (+0.21), GILD: 116.55 (+3.48), PFE: 35.71 (+0.36), COP: 52.72 (+0.48), XOM: 82.68 (+0.20), AMGN: 169.99 (-2.75), DD: 55.64 (-0.26), CVX: 92.68 (+0.28), SLB: 83.46 (+0.96), UPS: 100.60 (+0.66), CELG: 132.91 (-2.51)
Watch for Shares of Pfizer (PFE) to Approach Resistance at $36.14
Comtex SmarTrend(R) - Wed Jul 29, 9:04AM CDT
Pfizer (NYSE
FE) has opened bullishly above the pivot of $35.07 today and has reached the first level of resistance at $35.75. Investors may be interested in a cross of the next upside pivot targets of $36.14 and $37.21.
PFE: 35.71 (+0.36)
Top 10 New Stocks to Trade Like Hedge Fund Renaissance Technologies
at The Street - Wed Jul 29, 6:40AM CDT
Here's a closer look at Renaissance Technologies' 10 largest new holdings in the most recently reported quarter.
CCI: 82.14 (-0.12), AMZN: 526.96 (+0.93), FB: 96.12 (+0.83), PFE: 35.71 (+0.36), VFC: 75.31 (-0.34), WMT: 72.35 (+0.25), TWTR: 31.56 (-4.98), UNP: 97.07 (+0.45), REGN: 541.09 (-11.36), PCLN: 1,218.70 (+10.61)
Hospira Reports Second-Quarter 2015 Results
PR Newswire - Wed Jul 29, 6:30AM CDT
Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today reported results for the second quarter ended June 30, 2015. For the second quarter of 2015, net sales were $1.2 billion, and adjusted* diluted earnings per share were $0.85. (Adjusted* measures exclude certain specified items as described later in this press release and the attached schedules.) On a U.S. Generally Accepted Accounting Principles (GAAP) basis, second-quarter 2015 diluted earnings per share were $0.82.
PFE: 35.71 (+0.36), HSP: 89.26 (+0.03)
Pfizer (PFE) Earnings Report: Q2 2015 Conference Call Transcript
at The Street - Tue Jul 28, 8:12PM CDT
The following Pfizer (PFE) conference call took place on July 28, 2015, 10:00 AM ET. This is a transcript of that earnings call:
PFE: 35.71 (+0.36)
Big pharmas beat Q2 views
at Investor's Business Daily - Tue Jul 28, 5:42PM CDT
Pfizer's (PFE) EPS dipped 3% to 56 cents, topping by 4 cents. Sales declined 7% to $11.85 bil, ahead of views. It raised its full-year EPS to $2.01-$2.07, in line with views, and upped the low end of its sales guidance. Merck's (MRK) EPS rose 1% to...
MRK: 58.58 (+1.06), PFE: 35.71 (+0.36)
Pfizer, Merck Beat Q2 Views; Sanofi Makes PD-1 Deal
at Investor's Business Daily - Tue Jul 28, 4:32PM CDT
Big pharmas Pfizer (PFE) and Merck (MRK) both beat Q2 estimates and raised guidance Tuesday, while Merck and French counterpart Sanofi (SNY) entered into separate deals to develop immunotherapy drugs for cancer. Pfizer's earnings dipped 3% to 56...
MRK: 58.58 (+1.06), PFE: 35.71 (+0.36), BMY: 64.50 (-0.16), SNY: 53.88 (+0.07), REGN: 541.09 (-11.36)
After Yesterday's Rally of 2.94% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Jul 28, 4:29PM CDT
Pfizer (NYSEFE) traded in a range yesterday that spanned from a low of $34.40 to a high of $35.47. Yesterday, the shares gained 2.9%, which took the trading range above the 3-day high of $35.00 on volume of 36.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PFE: 35.71 (+0.36)
SmarTrend Watching for Potential Pullback in Shares of Pfizer After 2.94% Gain
Comtex SmarTrend(R) - Tue Jul 28, 4:28PM CDT
Pfizer (NYSEFE) traded in a range yesterday that spanned from a low of $34.40 to a high of $35.47. Yesterday, the shares gained 2.9%, which took the trading range above the 3-day high of $35.00 on volume of 36.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PFE: 35.71 (+0.36)
SuperValu and Pfizer are big market movers
AP - Tue Jul 28, 3:32PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
RAI: 83.82 (-0.38), QSR.TO: 55.54 (+0.19), RJET: 5.29 (+1.85), SVU: 8.69 (+0.55), PFE: 35.71 (+0.36), IR: 61.58 (+0.88), MYL: 57.08 (+0.73), BECN: 36.32 (+2.73), MAS: 26.06 (+0.43), PGNX: 8.80 (-0.62), QSR: 43.07 (+0.32), TEVA: 71.06 (-0.35), WAB: 101.25 (+1.63), IPGP: 92.03 (+2.32)
Stocks Rebound Sharply, Helped by Higher Oil Prices
at The Street - Tue Jul 28, 3:05PM CDT
Markets came back with a bang on Tuesday, rallying for the first time in six sessions.
F: 15.12 (+0.29), PFE: 35.71 (+0.36), XOM: 82.68 (+0.20), COP: 52.72 (+0.48), BP: 37.25 (-0.04), CVX: 92.68 (+0.28), PTR: 102.42 (+3.19), UPS: 100.60 (+0.66), XLE: 70.95 (+0.48)
Pfizer Beats Estimates On Strong Cancer Drug Sales
at The Street - Tue Jul 28, 2:01PM CDT
Pfizer reported earnings that beat estimates and raised its outlook for the year, as its newly launched drug treatments continued to perform well in the second quarter.
PFE: 35.71 (+0.36)
Stocks Rally as Crude Oil Closes Near $48
at The Street - Tue Jul 28, 2:00PM CDT
Stocks move confidently higher on Tuesday as the Federal Reserve kicks off a two-day meeting and crude oil prices rebound.
F: 15.12 (+0.29), BIDU: 168.25 (+0.22), PFE: 35.71 (+0.36), XOM: 82.68 (+0.20), COP: 52.72 (+0.48), BP: 37.25 (-0.04), CVX: 92.68 (+0.28), PTR: 102.42 (+3.19), UPS: 100.60 (+0.66), XLE: 70.95 (+0.48)
Drugmaker Pfizer tops Street 2Q forecasts, raises forecast
By LINDA A. JOHNSON - AP - Tue Jul 28, 12:35PM CDT
Pfizer Inc. beat Wall Street's second-quarter expectations and raised its 2015 forecast, as soaring sales for a few key products helped inoculate the world's second-largest drugmaker against a $1 billion revenue hit from foreign exchange rates and its last wave of cheap generic competition hurting former big sellers.
MRK: 58.58 (+1.06), PFE: 35.71 (+0.36), BMY: 64.50 (-0.16)
Stocks Turn Positive as Energy Sector Leads
at The Street - Tue Jul 28, 10:07AM CDT
Stocks bounce back to session highs by late morning Tuesday.
AMZN: 526.96 (+0.93), F: 15.12 (+0.29), HON: 105.56 (+1.36), PFE: 35.71 (+0.36), XOM: 82.68 (+0.20), COP: 52.72 (+0.48), UPS: 100.60 (+0.66), BIDU: 168.25 (+0.22), EBAY: 28.85 (+0.52), MRK: 58.58 (+1.06), DD: 55.64 (-0.26), BP: 37.25 (-0.04), PG: 80.77 (+0.54), CVX: 92.68 (+0.28), PTR: 102.42 (+3.19), XLE: 70.95 (+0.48)
China, the Fed Coming to Grips - Ahead of Wall Street
Sheraz Mian - Zacks Investment Research - Tue Jul 28, 9:27AM CDT
Stocks appear on track to start today's session in the green with a less-worrisome Chinese stock market, the Fed meeting and a barrage of earnings reports providing a mixed backdrop.
PFE: 35.71 (+0.36), DD: 55.64 (-0.26), UPS: 100.61 (+0.67)
Pfizer (PFE) Stock Climbs on Strong Earnings
at The Street - Tue Jul 28, 8:45AM CDT
Pfizer (PFE) shares are gaining after the company reported a drop in profit and revenues that still beat analysts' expectations.
PFE: 35.71 (+0.36)
Critical Alerts For ConocoPhillips, Teva, Pfizer Inc., Twitter and Invensense Released By InvestorsObserver
PR Newswire - Tue Jul 28, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for COP, TEVA, PFE, TWTR and INVN.
PFE: 35.71 (+0.36), INVN: 12.53 (-0.88), COP: 52.72 (+0.48), TEVA: 71.06 (-0.35), TWTR: 31.57 (-4.97)
Pfizer Beats on Q2 Earnings and Revenues, Revises Outlook - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Jul 28, 8:19AM CDT
Pfizer (PFE) raised the midpoint of its 2015 guidance range for revenues by $500 million and for earnings by 4 cents.
BAX: 38.39 (+0.30), PFE: 35.71 (+0.36), LLY: 85.06 (-0.62), HSP: 89.26 (+0.03)
Bull Chart of the Day: Pfizer
at The Street - 2 hrs 48 mins ago
PFE now has a very large bull flag with the potential to push the shares higher.
PFE: 35.71 (+0.36)
Stock Market News for July 29, 2015 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Jul 29, 9:10AM CDT
Benchmarks gained over 1% on Tuesday as investors focused on upbeat earnings results, ignoring the selloff in China’s stock market
BIIB: 311.50 (-8.43), F: 15.12 (+0.29), RIG: 14.33 (+0.21), GILD: 116.55 (+3.48), PFE: 35.71 (+0.36), COP: 52.72 (+0.48), XOM: 82.68 (+0.20), AMGN: 169.99 (-2.75), DD: 55.64 (-0.26), CVX: 92.68 (+0.28), SLB: 83.46 (+0.96), UPS: 100.60 (+0.66), CELG: 132.91 (-2.51)
Watch for Shares of Pfizer (PFE) to Approach Resistance at $36.14
Comtex SmarTrend(R) - Wed Jul 29, 9:04AM CDT
Pfizer (NYSE
FE) has opened bullishly above the pivot of $35.07 today and has reached the first level of resistance at $35.75. Investors may be interested in a cross of the next upside pivot targets of $36.14 and $37.21. PFE: 35.71 (+0.36)
Top 10 New Stocks to Trade Like Hedge Fund Renaissance Technologies
at The Street - Wed Jul 29, 6:40AM CDT
Here's a closer look at Renaissance Technologies' 10 largest new holdings in the most recently reported quarter.
CCI: 82.14 (-0.12), AMZN: 526.96 (+0.93), FB: 96.12 (+0.83), PFE: 35.71 (+0.36), VFC: 75.31 (-0.34), WMT: 72.35 (+0.25), TWTR: 31.56 (-4.98), UNP: 97.07 (+0.45), REGN: 541.09 (-11.36), PCLN: 1,218.70 (+10.61)
Hospira Reports Second-Quarter 2015 Results
PR Newswire - Wed Jul 29, 6:30AM CDT
Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today reported results for the second quarter ended June 30, 2015. For the second quarter of 2015, net sales were $1.2 billion, and adjusted* diluted earnings per share were $0.85. (Adjusted* measures exclude certain specified items as described later in this press release and the attached schedules.) On a U.S. Generally Accepted Accounting Principles (GAAP) basis, second-quarter 2015 diluted earnings per share were $0.82.
PFE: 35.71 (+0.36), HSP: 89.26 (+0.03)
Pfizer (PFE) Earnings Report: Q2 2015 Conference Call Transcript
at The Street - Tue Jul 28, 8:12PM CDT
The following Pfizer (PFE) conference call took place on July 28, 2015, 10:00 AM ET. This is a transcript of that earnings call:
PFE: 35.71 (+0.36)
Big pharmas beat Q2 views
at Investor's Business Daily - Tue Jul 28, 5:42PM CDT
Pfizer's (PFE) EPS dipped 3% to 56 cents, topping by 4 cents. Sales declined 7% to $11.85 bil, ahead of views. It raised its full-year EPS to $2.01-$2.07, in line with views, and upped the low end of its sales guidance. Merck's (MRK) EPS rose 1% to...
MRK: 58.58 (+1.06), PFE: 35.71 (+0.36)
Pfizer, Merck Beat Q2 Views; Sanofi Makes PD-1 Deal
at Investor's Business Daily - Tue Jul 28, 4:32PM CDT
Big pharmas Pfizer (PFE) and Merck (MRK) both beat Q2 estimates and raised guidance Tuesday, while Merck and French counterpart Sanofi (SNY) entered into separate deals to develop immunotherapy drugs for cancer. Pfizer's earnings dipped 3% to 56...
MRK: 58.58 (+1.06), PFE: 35.71 (+0.36), BMY: 64.50 (-0.16), SNY: 53.88 (+0.07), REGN: 541.09 (-11.36)
After Yesterday's Rally of 2.94% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Jul 28, 4:29PM CDT
Pfizer (NYSE
FE) traded in a range yesterday that spanned from a low of $34.40 to a high of $35.47. Yesterday, the shares gained 2.9%, which took the trading range above the 3-day high of $35.00 on volume of 36.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. PFE: 35.71 (+0.36)
SmarTrend Watching for Potential Pullback in Shares of Pfizer After 2.94% Gain
Comtex SmarTrend(R) - Tue Jul 28, 4:28PM CDT
Pfizer (NYSE
FE) traded in a range yesterday that spanned from a low of $34.40 to a high of $35.47. Yesterday, the shares gained 2.9%, which took the trading range above the 3-day high of $35.00 on volume of 36.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. PFE: 35.71 (+0.36)
SuperValu and Pfizer are big market movers
AP - Tue Jul 28, 3:32PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
RAI: 83.82 (-0.38), QSR.TO: 55.54 (+0.19), RJET: 5.29 (+1.85), SVU: 8.69 (+0.55), PFE: 35.71 (+0.36), IR: 61.58 (+0.88), MYL: 57.08 (+0.73), BECN: 36.32 (+2.73), MAS: 26.06 (+0.43), PGNX: 8.80 (-0.62), QSR: 43.07 (+0.32), TEVA: 71.06 (-0.35), WAB: 101.25 (+1.63), IPGP: 92.03 (+2.32)
Stocks Rebound Sharply, Helped by Higher Oil Prices
at The Street - Tue Jul 28, 3:05PM CDT
Markets came back with a bang on Tuesday, rallying for the first time in six sessions.
F: 15.12 (+0.29), PFE: 35.71 (+0.36), XOM: 82.68 (+0.20), COP: 52.72 (+0.48), BP: 37.25 (-0.04), CVX: 92.68 (+0.28), PTR: 102.42 (+3.19), UPS: 100.60 (+0.66), XLE: 70.95 (+0.48)
Pfizer Beats Estimates On Strong Cancer Drug Sales
at The Street - Tue Jul 28, 2:01PM CDT
Pfizer reported earnings that beat estimates and raised its outlook for the year, as its newly launched drug treatments continued to perform well in the second quarter.
PFE: 35.71 (+0.36)
Stocks Rally as Crude Oil Closes Near $48
at The Street - Tue Jul 28, 2:00PM CDT
Stocks move confidently higher on Tuesday as the Federal Reserve kicks off a two-day meeting and crude oil prices rebound.
F: 15.12 (+0.29), BIDU: 168.25 (+0.22), PFE: 35.71 (+0.36), XOM: 82.68 (+0.20), COP: 52.72 (+0.48), BP: 37.25 (-0.04), CVX: 92.68 (+0.28), PTR: 102.42 (+3.19), UPS: 100.60 (+0.66), XLE: 70.95 (+0.48)
Drugmaker Pfizer tops Street 2Q forecasts, raises forecast
By LINDA A. JOHNSON - AP - Tue Jul 28, 12:35PM CDT
Pfizer Inc. beat Wall Street's second-quarter expectations and raised its 2015 forecast, as soaring sales for a few key products helped inoculate the world's second-largest drugmaker against a $1 billion revenue hit from foreign exchange rates and its last wave of cheap generic competition hurting former big sellers.
MRK: 58.58 (+1.06), PFE: 35.71 (+0.36), BMY: 64.50 (-0.16)
Stocks Turn Positive as Energy Sector Leads
at The Street - Tue Jul 28, 10:07AM CDT
Stocks bounce back to session highs by late morning Tuesday.
AMZN: 526.96 (+0.93), F: 15.12 (+0.29), HON: 105.56 (+1.36), PFE: 35.71 (+0.36), XOM: 82.68 (+0.20), COP: 52.72 (+0.48), UPS: 100.60 (+0.66), BIDU: 168.25 (+0.22), EBAY: 28.85 (+0.52), MRK: 58.58 (+1.06), DD: 55.64 (-0.26), BP: 37.25 (-0.04), PG: 80.77 (+0.54), CVX: 92.68 (+0.28), PTR: 102.42 (+3.19), XLE: 70.95 (+0.48)
China, the Fed Coming to Grips - Ahead of Wall Street
Sheraz Mian - Zacks Investment Research - Tue Jul 28, 9:27AM CDT
Stocks appear on track to start today's session in the green with a less-worrisome Chinese stock market, the Fed meeting and a barrage of earnings reports providing a mixed backdrop.
PFE: 35.71 (+0.36), DD: 55.64 (-0.26), UPS: 100.61 (+0.67)
Pfizer (PFE) Stock Climbs on Strong Earnings
at The Street - Tue Jul 28, 8:45AM CDT
Pfizer (PFE) shares are gaining after the company reported a drop in profit and revenues that still beat analysts' expectations.
PFE: 35.71 (+0.36)
Critical Alerts For ConocoPhillips, Teva, Pfizer Inc., Twitter and Invensense Released By InvestorsObserver
PR Newswire - Tue Jul 28, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for COP, TEVA, PFE, TWTR and INVN.
PFE: 35.71 (+0.36), INVN: 12.53 (-0.88), COP: 52.72 (+0.48), TEVA: 71.06 (-0.35), TWTR: 31.57 (-4.97)
Pfizer Beats on Q2 Earnings and Revenues, Revises Outlook - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Jul 28, 8:19AM CDT
Pfizer (PFE) raised the midpoint of its 2015 guidance range for revenues by $500 million and for earnings by 4 cents.
BAX: 38.39 (+0.30), PFE: 35.71 (+0.36), LLY: 85.06 (-0.62), HSP: 89.26 (+0.03)
